The knowledge of the mechanisms of THs actions in cancer could lead to the identification of new therapeutic targets or to the use of the modulation of the thyroid status to improve treatment outcomes in patients. The overall aim of this special issue entitled "Thyroid hormone actions in cancer" includes the contribution and significance of TH´s direct actions on tumor cell proliferation, survival and dissemination; and the association of thyroid status with the risk and progression of oncologic pathologies. This Research Topic consists of two original research articles, one review and one systematic review. These articles include the study of hepatocellular carcinoma, glioblastoma, thyroid cancer, and pituitary adenoma as the research oncologic models.In the first original paper Godugu et al, evaluated if TH analogues have a role in efferocytosis, a process by which apoptotic cells are removed by phagocytic cells. Using in vitro and in vivo glioblastoma models authors examined how the apoptosis induced by the hormone analogue tetraiodothyroacetic acid (tetrac) and chemically modified tetrac actions initiated at the integrin αvβ3 on tumor cells, contribute to the clearance of apoptotic cells. In the other original research article, Lu et al used Mendelian randomization (MR) analysis to estimate the causal effect of hypothyroidism on the risk for hepatocellular carcinoma (HCC). Single-nucleotide polymorphisms (SNPs) associated with hypothyroidism were screened via a genome-wide association study (GWAS). They found that hypothyroidism has a protective causal association with HCC. On the other hand, Wang et al performed a systematic review of related original studies with the purpose of comprehensively evaluating the relationships between thyroid-related hormones and the risk of thyroid cancer (TC). The authors found a significant association between thyroid-related hormones (TSH, free T4, free T3) and the risk of TC in this study, but further research is needed to understand the underlying mechanisms. Finally, Li et al showed a rare case of pituitary adenoma producing both GH and TSH simultaneously, which is associated with hyperthyroidism and acromegaly.
4 Authors
- LL
Likui Lu
Institute for Fetology, the First Affiliated Hospital of Soochow University, China
- BW
Bangbei Wan
Reproductive Medical Center, Hainan Women and Children’s Medical Centre, China
- LL
Lingjun Li
Institute for Fetology, the First Affiliated Hospital of Soochow University, China
- MS
Miao Sun
Institute for Fetology, the First Affiliated Hospital of Soochow University, China
6 Authors
- ZW
Zheng Wang
Department of Thyroid and Breast Surgery, Yijishan Hospital of Wannan Medical College, China
- YL
Yuxin Lin
Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University, China
- YJ
Yixian Jiang
Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University, China
- RF
Rong Fu
Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University, China
- YW
Yabing Wang
Department of Thyroid and Breast Surgery, Yijishan Hospital of Wannan Medical College, China
- QZ
Qian Zhang
Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University, China
5 Authors
- KG
Kavitha Godugu
Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, United States
- SA
Shaker A. Mousa
Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, United States
- GV
Gennadi V. Glinsky
Institute of Engineering in Medicine, University of California, United States
- HL
Hung-Yun Lin
Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taiwan
- PJ
Paul J. Davis
Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, United States
2,127 views
1,923 views

